721 related articles for article (PubMed ID: 19028374)
1. Antipsychotic drug use among elderly nursing home residents in the United States.
Kamble P; Chen H; Sherer J; Aparasu RR
Am J Geriatr Pharmacother; 2008 Oct; 6(4):187-97. PubMed ID: 19028374
[TBL] [Abstract][Full Text] [Related]
2. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.
Kamble P; Chen H; Sherer JT; Aparasu RR
Drugs Aging; 2009; 26(6):483-92. PubMed ID: 19591523
[TBL] [Abstract][Full Text] [Related]
3. Off-label use of second-generation antipsychotic agents among elderly nursing home residents.
Kamble P; Sherer J; Chen H; Aparasu R
Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817
[TBL] [Abstract][Full Text] [Related]
4. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004.
Jano E; Johnson M; Chen H; Aparasu RR
Curr Med Res Opin; 2008 Mar; 24(3):709-16. PubMed ID: 18226325
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.
Chatterjee S; Mehta S; Sherer JT; Aparasu RR
Drugs Aging; 2010 Dec; 27(12):987-97. PubMed ID: 21087068
[TBL] [Abstract][Full Text] [Related]
6. Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics.
Aparasu RR; Chatterjee S; Chen H
Ann Pharmacother; 2013 Apr; 47(4):464-74. PubMed ID: 23548651
[TBL] [Abstract][Full Text] [Related]
7. An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.
Phillips LJ; Birtley NM; Petroski GF; Siem C; Rantz M
J Psychiatr Ment Health Nurs; 2018 Oct; 25(8):463-474. PubMed ID: 29911331
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.
Dwyer LL; Han B; Woodwell DA; Rechtsteiner EA
Am J Geriatr Pharmacother; 2010 Feb; 8(1):63-72. PubMed ID: 20226393
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts.
Richter T; Mann E; Meyer G; Haastert B; Köpke S
J Am Med Dir Assoc; 2012 Feb; 13(2):187.e7-187.e13. PubMed ID: 21549645
[TBL] [Abstract][Full Text] [Related]
11. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
Aparasu RR; Jano E; Johnson ML; Chen H
Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
[TBL] [Abstract][Full Text] [Related]
12. Assessment of antipsychotic prescribing in Belgian nursing homes.
Azermai M; Elseviers M; Petrovic M; van Bortel L; Stichele RV
Int Psychogeriatr; 2011 Oct; 23(8):1240-8. PubMed ID: 21418723
[TBL] [Abstract][Full Text] [Related]
13. Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.
Aparasu RR; Bhatara V
Curr Med Res Opin; 2007 Jan; 23(1):49-56. PubMed ID: 17257465
[TBL] [Abstract][Full Text] [Related]
14. Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents.
Aparasu RR; Chatterjee S; Mehta S; Chen H
Med Care; 2012 Nov; 50(11):961-9. PubMed ID: 23047786
[TBL] [Abstract][Full Text] [Related]
15. Clinical, demographic, and pharmacologic features of nursing home residents with Huntington's disease.
Zarowitz BJ; O'Shea T; Nance M
J Am Med Dir Assoc; 2014 Jun; 15(6):423-8. PubMed ID: 24613270
[TBL] [Abstract][Full Text] [Related]
16. Variation in antipsychotic treatment choice across US nursing homes.
Huybrechts KF; Rothman KJ; Brookhart MA; Silliman RA; Crystal S; Gerhard T; Schneeweiss S
J Clin Psychopharmacol; 2012 Feb; 32(1):11-7. PubMed ID: 22198446
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic use and the risk of diabetes in nursing home residents with dementia.
Jalbert JJ; Daiello LA; Eaton CB; Miller SC; Lapane KL
Am J Geriatr Pharmacother; 2011 Jun; 9(3):153-63. PubMed ID: 21596626
[TBL] [Abstract][Full Text] [Related]
18. Why and how antipsychotic drugs are used in 40 Sydney nursing homes.
Snowdon J; Day S; Baker W
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey.
Seitz DP; Gruneir A; Conn DK; Rochon PA
J Am Geriatr Soc; 2009 Dec; 57(12):2269-74. PubMed ID: 19874411
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.
Bhattacharya R; Chatterjee S; Carnahan RM; Aparasu RR
Am J Geriatr Pharmacother; 2011 Dec; 9(6):434-41. PubMed ID: 22030114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
